Atlas Trials

QT Interval/Corrected QT Interval (QT/QTc) Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants

Clinical trial NCT07708272 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07708272
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Myelofibrosis
Start date
2026-07-30
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.